Literature DB >> 3164041

Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy.

S J Kish1, L Schut, J Simmons, J Gilbert, L J Chang, M Rebbetoy.   

Abstract

The activity was measured of the acetylcholine catabolising enzyme acetylcholinesterase (AChE) in brain after necropsy of seven patients from one established pedigree with dominantly-inherited olivopontocerebellar atrophy (OPCA), a cerebellar ataxia disorder in which neuropathological changes are assumed to be primarily restricted to cerebellum, lower brain stem and spinal cord. Mean AChE activity was significantly reduced in cerebral (-51% to 65%) and cerebellar (-47%) cortex with a less severe change (-37%) in the hippocampus. The magnitude of the enzyme reduction in cerebral cortex was equal to or greater than that reported in brain of demented Alzheimer's and Parkinson's disease patients having loss of AChE-containing nucleus basalis cholinergic neurons. It is concluded that the data provide additional biochemical evidence suggesting a cerebral cortical cholinergic denervation in OPCA.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3164041      PMCID: PMC1032971          DOI: 10.1136/jnnp.51.4.544

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  A rapid radiochemical method for the determination of choline acetyltransferase.

Authors:  F Fonnum
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

2.  Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities.

Authors:  D M Landis; R N Rosenberg; S C Landis; L Schut; W L Nyhan
Journal:  Arch Neurol       Date:  1974-11

Review 3.  The organization and some projections of cholinergic neurons of the mammalian forebrain.

Authors:  H C Fibiger
Journal:  Brain Res       Date:  1982-11       Impact factor: 3.252

4.  Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey.

Authors:  M M Mesulam; E J Mufson; A I Levey; B H Wainer
Journal:  J Comp Neurol       Date:  1983-02-20       Impact factor: 3.215

Review 5.  The cholinergic hypothesis of geriatric memory dysfunction.

Authors:  R T Bartus; R L Dean; B Beer; A S Lippa
Journal:  Science       Date:  1982-07-30       Impact factor: 47.728

6.  A post-mortem study of the cholinergic and GABA systems in senile dementia.

Authors:  M N Rossor; N J Garrett; A L Johnson; C Q Mountjoy; M Roth; L L Iversen
Journal:  Brain       Date:  1982-06       Impact factor: 13.501

7.  Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form.

Authors:  J R Atack; E K Perry; J R Bonham; R H Perry; B E Tomlinson; G Blessed; A Fairbairn
Journal:  Neurosci Lett       Date:  1983-09-30       Impact factor: 3.046

8.  [14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex.

Authors:  N R Sims; D M Bowen; A N Davison
Journal:  Biochem J       Date:  1981-06-15       Impact factor: 3.857

9.  Acetylcholinesterase and butyrylcholinesterase measurement in the pre-natal detection of neural tube defects and other fetal malformations.

Authors:  J R Bonham; A H Gowenlock; J A Timothy
Journal:  Clin Chim Acta       Date:  1981-09-10       Impact factor: 3.786

10.  Immunohistochemical localization of choline acetyltransferase in the human cerebellum.

Authors:  K S Kan; L P Chao; L S Forno
Journal:  Brain Res       Date:  1980-07-07       Impact factor: 3.252

View more
  6 in total

Review 1.  Pharmacological treatments of cerebellar ataxia.

Authors:  Masafumi Ogawa
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

Review 2.  Behavioral screening for cognition enhancers: from indiscriminate to valid testing: Part II.

Authors:  M Sarter; J Hagan; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment.

Authors:  Xiao-Xiao Fu; Jin Wang; Hua-Ying Cai; Hong Jiang; Jin-Zhan Jiang; Hao-Hao Chen; Shu Han
Journal:  J Inflamm Res       Date:  2022-07-07

Review 4.  Cognitive Changes in the Spinocerebellar Ataxias Due to Expanded Polyglutamine Tracts: A Survey of the Literature.

Authors:  Evelyn Lindsay; Elsdon Storey
Journal:  Brain Sci       Date:  2017-07-14

5.  Cognition in Trinucleotide Repeat Spinocerebellar Ataxias: A Review.

Authors:  Ayush Agarwal; Mohd Faruq; Ajay Garg; Achal K Srivastava
Journal:  Ann Indian Acad Neurol       Date:  2022-09-09       Impact factor: 1.714

Review 6.  Cognition in hereditary ataxia.

Authors:  Katrin Bürk
Journal:  Cerebellum       Date:  2007       Impact factor: 3.648

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.